Basically, Abbott has a lot of restrictions on what can be disclosed to the public. My guess is that it has to do with the competitive edge, perhaps because of the semi-exclusive nature of the licensing agreement. So I wouldn't expect to hear much in any major news outlets. Maybe with approval by the FDA and/or commercialization. I would put as much $ as I could into this baby @ these levels, because this is going to be huge!!! IMO, 1-2 years from now we will be trading well above $5 ps.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.